Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 26.7 -4.78% -1.34
BOLT closed down 4.78 percent on Friday, February 26, 2021, on 63 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical BOLT trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction -4.78%
NR7 Range Contraction -4.78%
NR7-2 Range Contraction -4.78%
Inside Day Range Contraction -4.78%
New 52 Week Closing Low Bearish -2.91%
Hot IPO Pullback Bullish Swing Setup -2.91%
NR7 Range Contraction -2.91%
Inside Day Range Contraction -2.91%
Older End-of-Day Signals for BOLT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
Classification

Sector: Other
Industry: Other
Keywords: Medicine Clinical Medicine Pharmaceutical Products Cancer Immunotherapy Tumors Her2/Neu Immune Checkpoint Breast Cancers

Is BOLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.88
52 Week Low 22.63
Average Volume 322,728
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 30.67
Average True Range 3.79
ADX 0.0
+DI 6.59
-DI 20.52
Chandelier Exit (Long, 3 ATRs ) 24.51
Chandelier Exit (Short, 3 ATRs ) 34.00
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -1.25
MACD Signal Line -0.52
MACD Histogram -0.7271
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.55
Resistance 3 (R3) 29.73 28.96 29.08
Resistance 2 (R2) 28.96 28.23 28.87 28.92
Resistance 1 (R1) 27.83 27.79 27.45 27.65 28.76
Pivot Point 27.06 27.06 26.87 26.97 27.06
Support 1 (S1) 25.93 26.33 25.55 25.75 24.64
Support 2 (S2) 25.16 25.89 25.07 24.48
Support 3 (S3) 24.03 25.16 24.33
Support 4 (S4) 23.85